{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T18:55:37Z","timestamp":1754160937324,"version":"3.41.2"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010353","name":"Hellenic Atherosclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.cpcardiol.2025.103121","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:18:27Z","timestamp":1751422707000},"page":"103121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics and clinical outcomes in malignant phase hypertension patients using cluster analysis: A report from the West Birmingham Malignant Hypertension Registry"],"prefix":"10.1016","volume":"50","author":[{"given":"Antonios A.","family":"Argyris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0594-8576","authenticated-orcid":false,"given":"Alena","family":"Shantsila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Shantsila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Gareth","family":"Beevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.\u202f\u202fH.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2025.103121_bib0001","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.110.166314","article-title":"Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension","volume":"57","author":"Shantsila","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023397","article-title":"Malignant hypertension: current perspectives and challenges","volume":"11","author":"Boulestreau","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0003","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1097\/01.hjh.0000249710.21146.38","article-title":"Ethnic disparities in the incidence, presentation and complications of malignant hypertension","volume":"24","author":"van den Born","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/ajh.2009.153","article-title":"Improving survival of malignant hypertension patients over 40 years","volume":"22","author":"Lane","year":"2009","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/jhh.2015.112","article-title":"From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency","volume":"30","author":"Cremer","year":"2016","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0006","article-title":"Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort","author":"Rubin","year":"2018","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41371-019-0267-y","article-title":"Malignant hypertension: does this still exist?","volume":"34","author":"Domek","year":"2020","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0008","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/00004872-199508000-00013","article-title":"Complications and survival of 315 patients with malignant-phase hypertension","volume":"13","author":"Lip","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0009","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","article-title":"Long-term renal survival in malignant hypertension","volume":"25","author":"Gonzalez","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/jch.12243","article-title":"Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study","volume":"16","author":"Amraoui","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0011","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1097\/HJH.0000000000001446","article-title":"Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry","volume":"35","author":"Shantsila","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0012","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/HJH.0000000000001913","article-title":"Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort","volume":"37","author":"Rubin","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/a-1467-2993","article-title":"Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0014","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry phase II and III","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2022.842306","article-title":"Phenotype clustering in health care: a narrative review for clinicians","volume":"5","author":"Loftus","year":"2022","journal-title":"Front Artif Intell"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0016","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jacc.2018.12.054","article-title":"Artificial Intelligence in Cardiovascular Imaging: JACC State-of-the-art review","volume":"73","author":"Dey","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013924","article-title":"State-of-the-art machine learning techniques aiming to improve patient outcomes pertaining to the cardiovascular system","volume":"9","author":"Sevakula","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0018","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the 'Atrial fibrillation better care' Pathway in patients with atrial fibrillation: impact on clinical outcomes-A systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0019","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/a-1632-1777","article-title":"Novel clinical concepts in thrombosis\": integrated care for stroke management-easy as ABC","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0043-1772773","article-title":"Non-vitamin K antagonist oral anticoagulant, Warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry","volume":"124","author":"Treewaree","year":"2024","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0021","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/00004872-199411000-00013","article-title":"The failure of malignant hypertension to decline: a survey of 24 years' experience in a multiracial population in England","volume":"12","author":"Lip","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0022","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/HJH.0b013e3283526e47","article-title":"Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study","volume":"30","author":"Shantsila","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0023","unstructured":"TwoStep cluster analysis - IBM documentation. https:\/\/www.ibm.com\/docs\/en\/spss-statistics\/28.0.0?topic=features-twostep-cluster-analysis."},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0024","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Zheng","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cpcardiol.2025.103121_bib0025","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"Grymonprez","year":"2023","journal-title":"Thromb Haemost"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280625001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:06:58Z","timestamp":1753690018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280625001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0146280625001422"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103121","relation":{},"ISSN":["0146-2806"],"issn-type":[{"type":"print","value":"0146-2806"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics and clinical outcomes in malignant phase hypertension patients using cluster analysis: A report from the West Birmingham Malignant Hypertension Registry","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2025.103121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103121"}}